PREPARATION FOR THE PREVENTION AND/OR TREATMENT OF VASCULAR DISORDERS
First Claim
Patent Images
1. A method for prevention and/or treatment of degeneration of cerebral function, cognitive degeneration and/or dementia syndromes, comprising administering to a person in need thereof a preparation, comprising:
- a) long chain polyunsaturated fatty acid fraction comprising eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA);
b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and
c) at least one factor in methionine metabolism selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium, zinc, and equivalents thereof.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions:
- fraction a) consisting of long chain polyunsaturated fatty acids;
- fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine.
- fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.
30 Citations
27 Claims
-
1. A method for prevention and/or treatment of degeneration of cerebral function, cognitive degeneration and/or dementia syndromes, comprising administering to a person in need thereof a preparation, comprising:
-
a) long chain polyunsaturated fatty acid fraction comprising eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA); b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and c) at least one factor in methionine metabolism selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium, zinc, and equivalents thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)
-
-
27. A method for prevention and/or treatment of vascular disorders or disorders associated therewith, comprising administering to a person in need thereof a preparation, comprising:
-
a) long chain polyunsaturated fatty acid fraction comprising eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA); b) at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine; and c) at least one factor in methionine metabolism selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium, zinc, and equivalents thereof.
-
Specification